Interpace Biosciences Announces Improved Coverage for ThyGeNEXT® and ThyraMIR®
03 mai 2021 08h00 HE
|
Interpace Biosciences, Inc.
Parsippany, NJ, May 03, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today that eviCore Healthcare (“eviCore”), a wholly owned...